• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The function and structure of proteoheparan sulfate in the endothelial cell basement membrane.

Research Project

Project/Area Number 02670398
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Circulatory organs internal medicine
Research InstitutionKochi Medical School

Principal Investigator

MATSUBAYASHI Kozo (1991)  Kochi Medical School, Department of Geriatrics, Assis. Prof., 医学部, 講師 (70190494)

島田 和幸 (1990)  高知医科大学, 医学部, 講師 (90145128)

Co-Investigator(Kenkyū-buntansha) SHIMADA Kazuyuki  Jichi Medical School, Department of Cardiology, Prof., 医学部, 教授 (90145128)
松林 公蔵  高知医科大学, 医学部, 助手 (70190494)
Project Period (FY) 1990 – 1991
Project Status Completed (Fiscal Year 1991)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1991: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1990: ¥1,400,000 (Direct Cost: ¥1,400,000)
KeywordsEndothelial Cell / Extracellular matrix / Basement membrane / Proteoglycan / Heparan sulfate / Heparin / Antithrombin III / Anticoagulant activity
Research Abstract

It is thought that the non-thrombogenic properties of blood vessels are partially regulated by anticoagulantly active heparin-like compoundson the luminal surface of vascular endotherial cells. Heparan sulfate proteoglycans(HSPGS)are also known to be located along the abluminal side of the endothelium, that is, basement membrane or extracellular matrix(ECM)of endothelial cells. Does ECM contain HSPG which interact with antithrombin III (AT III)? If so, how abundant are they, as compared with those on the luminal surface? To answer this question, we have studied the interaction of ^<125>I -labeled AT III with cultured porcine aortic endothelial cells to localize the cellular site of anticoagulantly active HSPGS. ECM, prepared from endothelial cells cultured on plastic dishes, by removing the cells with nonenzymatic methods, specifically bound ^<125>I-AT III. The amount of AT III bound to ECM was approximately 40% of that bound to the intact cell. The binding was efficiently displaced by … More heparan sulfate, and almost completely abolished by pretreatment of ECM with Flavobacterium heparitinase. ECM associated HSPGs apparently represented approximately 40% of HSPGs associated with intact cell, in parallel with the binding experiments. Approximately 15-20% of ECM-associated ^<35>S-glycosaminoglycans was bound to AT III affinity column with high affinity. ECM accelerated inactivation of thrombin by AT III. Based upon the above data, we conclude that approximately at least a half of anticoagulantly active HSPG is located in the ECM, that is, abluminal side of cultured aortic endothelial cells. The physiological significance of this finding remains to be determined.
In the next series of experiments, ECM was solubilized and applied onto the DEAE-Sephacell chromatography. Proteoheparan sulfate was eluted first at approximately 0.35 M NaCl followed by chondroitin sulfates. This fraction was concentrated and was subjected to SDS-PAGE(3-11%). Only after digestions with heparitinase, the protein band was migrated into separating gel plate, showing an apparent molecular weight of>200, 000. Further purifications are currently underway. Less

Report

(3 results)
  • 1991 Annual Research Report   Final Research Report Summary
  • 1990 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Kobayashi M,Shimada K,Ozawa T.: "Human recombinant interleukin-1β-and tumor necrosis factor α-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells." Journal of Cellular Physiology. 144. 383-390 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 島田 和幸: "血管壁グリコサミノグリカンと血栓" 日本血栓止血学会誌. 1. 73-83 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 島田 和幸: "血管内皮細胞の抗凝固性とヘパリン様物質" 臨床病理. 86. 116-123 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Shimada K,Kobayashi M,Ozawa T,et al.: "Anticoagulant Heparin-like Glycosaminoglycans on Endothelial Cell Surface." Japanese Circulation Journal. 55. 1016-1021 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Takeuchi K,Shimada K,Nishinaga M,Kimura S,Ozawa T.: "Localization of heparin-like Compounds in Cultured Aortic Endothelial Cells." Haemostasis and Circulation.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Kobayashi M,Shimada K,Ozawa T.: "Human Platelet-Derived Trensforming Growth Factor-β stimulates Synthesis of Glycosaminoglycans in Cultured Porcine Aortic Endothelial Cells." Gerontology.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 島田 和幸(折茂 肇編): "血管壁細胞の機能とその制御機構" 共立出版社, 181 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 島田 和幸(住吉 昭信,斉藤 康編): "動脈硬化発生・進展の解明" 共立出版社, 157 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Kobayashi M et al: "Human recombinant interleukin-1B- and tumor necrosis factor a-mediated suppression or heparin-like compounds on cultured porcine aortic endothelial cells." Journal of Cellular Physiology. 144. 383-390 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Kobayashi M,Shimada K,Ozawa T.: "Human recombinant interleukinー1βーand tumor necrosis factor αーmediated suppression of heparinーlike compounds on cultured porcine aortic endothelial cells." Journal of Cellular Physiology. 144. 383-390 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 島田 和幸: "血管壁グリコサミノグリカンと血栓" 日本血栓止血学会誌. 1. 73-83 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 島田 和幸: "血管内皮細胞の抗凝固性とヘパリン様物質" 臨床病理. 86. 116-123 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] Shimada K,Kobayashi M,Ozawa T,et al.: "Anticoagulant Heparinーlike Glycosaminoglycans on Endothelial Cell Surface" Japanese Circulation Journal. 55. 1016-1021 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Takeuchi K,Shimada K,Nishinaga M,Kimura S,Ozawa T.: "Localization of Heparinーlike Compounds in Cultured Aortic Endothelial Cells." Haemostasis and Circulation.

    • Related Report
      1991 Annual Research Report
  • [Publications] Kobayashi M,Shimada K,Ozawa T.: "Human PlateletーDerived Transforming Growth Factorーβ Stimulates Synthesis of Glycosaminoglycans in Cultured Porcine Aortic Endothelial Cells." Gerontology.

    • Related Report
      1991 Annual Research Report
  • [Publications] 折茂 肇 編,島田 和幸: "血管壁細胞の機能とその制御機構" 共立出版社, 181 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 住吉 昭信,斉藤 康 編,島田 和幸: "動脈硬化発生・進展の解明" 共立出版社, 157 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Kobayashi M,Shimada K,Ozawa T.: "Human recombinant interleukinー1βー and tumor necrosis factor αーmediated suppression of heparinーlike compounds on cultured porcine aortic endothelial cells" Journal of Cellular Physiology. 144. 383-390 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] 島田 和幸: "血管壁グリコサミノグリカンと血栓" 日本血栓止血学会誌. 1. 73-83 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] 島田 和幸: "血管内皮細胞の抗凝固性とヘパリン様物質" 臨床病理. 86. 116-123 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] 島田 和幸(折茂 肇編): "血管壁細胞の機能とその制御機構" 共立出版社, 181 (1990)

    • Related Report
      1990 Annual Research Report

URL: 

Published: 1990-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi